Research progress on biomarkers in the diagnosis and treatment of idiopathic pulmonary fibrosis
10.3760/cma.j.cn114452-20240816-00461
- VernacularTitle:特发性肺纤维化诊断与预后生物标志物研究进展
- Author:
Lijuan HU
1
;
Ruoyu LIU
;
Yun ZHOU
;
Yongtong CAO
Author Information
1. 北京协和医学院研究生院，北京100730
- Keywords:
Pulmonary fibrosis;
Interstitial lung disease;
Biomarkers;
Clinical application
- From:
Chinese Journal of Laboratory Medicine
2024;47(10):1123-1125
- CountryChina
- Language:Chinese
-
Abstract:
Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease that is difficult to diagnose clinically, and finding appropriate biomarkers to assist in the diagnosis and prognosis monitoring of IPF can improve the proportion of early diagnosis and timely treatment of these patients and improve the quality of life of patients
